Koss-Olinger Consulting’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $541K | Sell |
2,913
-67
| -2% | -$12.4K | 0.04% | 191 |
|
|
2025
Q1 | $624K | Buy |
+2,980
| New | +$624K | 0.05% | 158 |
|
|
2024
Q4 | – | Sell |
-2,566
| Closed | -$507K | – | 186 |
|
|
2024
Q3 | $507K | Buy |
2,566
+400
| +18% | +$79K | 0.04% | 159 |
|
|
2024
Q2 | $371K | Buy |
+2,166
| New | +$371K | 0.03% | 183 |
|
|
2024
Q1 | – | Sell |
-1,912
| Closed | -$296K | – | 47 |
|
|
2023
Q4 | $296K | Sell |
1,912
-46
| -2% | -$7.12K | 0.03% | 239 |
|
|
2023
Q3 | $292K | Buy |
1,958
+280
| +17% | +$41.8K | 0.04% | 194 |
|
|
2023
Q2 | $226K | Hold |
1,678
| – | – | 0.03% | 234 |
|
|
2023
Q1 | $267K | Sell |
1,678
-161
| -9% | -$25.6K | 0.03% | 188 |
|
|
2022
Q4 | $297K | Sell |
1,839
-654
| -26% | -$106K | 0.04% | 161 |
|
|
2022
Q3 | $335K | Buy |
2,493
+318
| +15% | +$42.7K | 0.06% | 133 |
|
|
2022
Q2 | $333K | Sell |
2,175
-616
| -22% | -$94.3K | 0.06% | 120 |
|
|
2022
Q1 | $452K | Sell |
2,791
-1,227
| -31% | -$199K | 0.07% | 108 |
|
|
2021
Q4 | $544K | Buy |
4,018
+336
| +9% | +$45.5K | 0.08% | 98 |
|
|
2021
Q3 | $397K | Sell |
3,682
-1,121
| -23% | -$121K | 0.06% | 141 |
|
|
2021
Q2 | $541K | Buy |
4,803
+421
| +10% | +$47.4K | 0.08% | 126 |
|
|
2021
Q1 | $474K | Buy |
+4,382
| New | +$474K | 0.08% | 132 |
|